Integrated Biosciences
optogenetics, chemistry, AI
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
optogenetics, chemistry, AI
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Integrated Biosciences optogenetics, chemistry, AI
Integrated Biosciences is advancing a pipeline of novel small molecule therapeutics for age-related diseases. Its platform combines synthetic biology, chemistry, and AI to probe disease biology and explore chemical space. The company states its science is built on pioneering work from scientific co-founder Prof. Jim Collins at MIT.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Integrated Biosciences — Early mechanism · Lower middle. Derived deterministically from 6 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic